M
MBX Biosciences Inc
NASDAQ:MBX
MBX Biosciences Inc
NASDAQ:MBX
Price:
36.05
USD
-6.05%
Market Closed
Market Cap:
$1.6B
Cash Flow Statement
Cash Flow Statement
MBX Biosciences Inc
MBX Biosciences Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(39)
|
(47)
|
(65)
|
(62)
|
(73)
|
(77)
|
(80)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
3
|
4
|
3
|
5
|
5
|
6
|
10
|
|
| Other Non-Cash Items |
2
|
3
|
3
|
2
|
2
|
2
|
3
|
|
| Change in Working Capital |
(1)
|
1
|
4
|
5
|
5
|
4
|
(1)
|
|
| Cash from Operating Activities |
(37)
N/A
|
(43)
-16%
|
(58)
-34%
|
(55)
+5%
|
(67)
-22%
|
(71)
-6%
|
(78)
-10%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
(12)
|
(39)
|
(140)
|
(160)
|
(172)
|
(138)
|
(20)
|
|
| Cash from Investing Activities |
(12)
N/A
|
(40)
-229%
|
(141)
-252%
|
(161)
-14%
|
(173)
-8%
|
(139)
+20%
|
(21)
+85%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
69
|
69
|
307
|
238
|
238
|
240
|
190
|
|
| Other |
(0)
|
(2)
|
(4)
|
(4)
|
(4)
|
(3)
|
(1)
|
|
| Cash from Financing Activities |
69
N/A
|
67
-3%
|
303
+352%
|
234
-23%
|
234
0%
|
237
+1%
|
189
-20%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
20
N/A
|
(16)
N/A
|
104
N/A
|
19
-82%
|
(6)
N/A
|
27
N/A
|
90
+231%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(37)
N/A
|
(44)
-17%
|
(58)
-34%
|
(56)
+5%
|
(67)
-21%
|
(72)
-7%
|
(79)
-10%
|
|
Switch to:
Switch to:
See Also
Discover More
